Harvey in 2025: $600M Raised, $5B Valued, and Still Going
The company is expanding its platform for services such as tax and accounting
AI at work across drug discovery, clinical trials and life sciences.
Research: AIM Research reports on Pharma AI →Page 17
The company is expanding its platform for services such as tax and accounting
We see a real opportunity to step on the gas and be as aggressive as possible.
“The best products today? They don’t own the model - they wrap it in the best context + UX.”
“We believe this is the decade where foundation models transform medicine. We’re just getting started.”
Pano AI just announced a $44 million Series B funding round led by Giant Ventures
"Most of all, it’s about getting people the care they need, faster and with less friction.”
"AI is transforming how enterprises access and leverage data but also how they lose it."
The month's funding landscape demonstrated continued investor confidence in AI-driven solutions
"We don't want to slow down during one of the most historic opportunities for growth in AI"
Cancer Care App Outcomes4Me just raised $21 million in funding
“We’re giving humans superpowers... With AI, we can make healthcare more personal, connected, preventative, and accessible, for everyone.”
The services offered by Harvey represent the future of legal and compliance work.
We realized it's better for us and better for the industry if instead of keeping the technology for ourselves, we built tools to empower every home health provider.
The platform, which began as a collaboration with NVIDIA, has evolved into a multi-cloud, hybrid system
It links every AI output back to its source data, model, and logic, creating full decision traceability.
Freed transforms patient visits by listening in, transcribing conversations, and generating draft medical notes in real time
After a decade of consolidation, Veeva is testing whether agentic AI can operate inside GxP workflows without breaking core controls
Several companies are combining neuroscience, machine learning, and engineering in practical ways to create systems that process information like the human brain.
The newly secured funding will enable Inductive Bio to expand its AI model research and development, grow its data consortium, and deploy its technology industry-wide
Our AI engine takes the raw data across blood, genetic, and wearable data and distills it into clear insights that guide users step by step.